Cham, Bill Elliot,Chase, Tania Robyn,Cham, Kai Eillot
申请号：
AU2017225912
公开号：
AU2017225912A1
申请日:
2017.03.03
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
The present invention relates to the use of glycoalkaloids, such as solasonine and solamargine, in treatment of cancer such as skin cancer, and to compositions for use in such treatment. More particularly the present invention relates to providing an improved, substantially stable formulation for the glycoalkaloids which minimises or reduces degradation of these active molecules.
